Company / PP&E (Net)
Minerva Neurosciences, Inc. PP&E (Net) History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$5.4K
FY2024
5-year range
$5.4K / $16.3K
FY2020-FY2024
Trend
-50.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $16,326 to $5,442 over the past 2 years.
Based on SEC 10-K filings.
$5,442 in FY2024 with a 5-year CAGR of -19.4%.
Declined from $16,326 to $5,442 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -19.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -19.4%, indicating a declining trend.
- In FY2024, pp&e (net) decreased 50.0% year-over-year.
- Peak pp&e (net) was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.4K | -50.0% |
| FY2023 | $10.9K | -33.3% |
| FY2022 | $16.3K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $16.0K | -52.2% |
| FY2018 | $33.5K | -34.3% |
| FY2017 | $50.9K | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026